Collecting, evaluating and managing evidence is the most crucial part of research that drives policy and regulates medical technologies, and Systematic Reviews are the cornerstone of evidence-based research. A Systematic Review may contain tens of thousands of...

Joanna Lansche
For the Record with Peter O’Blenis, CEO at DistillerSR
In a recent interview to Medical Alley, Peter O’Blenis, CEO at DistillerSR, discussed the company's innovation track record and the results of a recent market survey conducted with medical device and in-vitro diagnostics manufacturers, shedding light on how automation...
Webinar Recap: NuVasive and Geistlich Pharma Share Best Practices for EU MDR State of the Art Submissions While Achieving More Efficient Literature Reviews with DistillerSR
In a recent webinar, DistillerSR customers Monique Liston, Senior Medical Writer at NuVasive and Shelley Jambresic, Senior Clinical Evaluations Manager at Geistlich Pharma were joined by Dr. Bassil Akra, founder and CEO of Akra Team GmbH, Dr. Julien Senac, Global...
PRISMA Statement: Interviewing the Lead Author of the Updated PRISMA 2020 Statement on Systematic Reviews
The publication of the original PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analysis) statement in 2009 ushered in a paradigm shift in the importance of transparent reporting in systematic reviews. The statement is endorsed by several hundred...
Webinar Recap: Streamlining Health Technology Assessments by Automating Literature Reviews
At our recent webinar, we were joined by Maria Arregui, Ph.D. Assistant Director, Evidence Generation and Communications at Xcenda; Chris Waters-Banker, Ph.D. Director of Consulting Operations at Maple Health Group; Rajshree Pandey, Ph.D. Associate Director, Evidence...
ICON Q&A: How Can Automation Support Literature Surveillance for Pharmacovigilance?
Andrew Purchase, Director of Pharmacovigilance & Patient Safety and UK QPPV at ICON sat down with Vivian MacAdden, Senior Manager, Industry Marketing at DistillerSR to discuss the critical role of literature surveillance in the pharmaceutical and biotechnology...
5 Ways We Use DistillerSR Filters to Streamline My SLR Processes
As the Director of Consulting Operations for Maple Health Group, I conduct both targeted and systematic literature reviews (TLRs and SLRs) in addition to working with consultants within my organization to improve the efficiency in which we conduct these reviews. Our...
Webinar Recap: How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
At our recent webinar, we were joined by Dr. Shirley Sylvester, Therapeutic Area Medical Affairs Leader, Infectious Diseases and Vaccines at Johnson & Johnson, Vardhini Ganesh, Associate Bioinformatician, Immunology - Vaccine at Sanofi, Dr. Richa Goyal Rai,...
Webinar Recap: Johnson & Johnson and Philips On Their Journey to Streamline Post-Market Surveillance Literature Reviews for EU MDR/IVDR Submissions with DistillerSR
In a recent webinar, DistillerSR customers Christa Goode, Director of Clinical and Medical Affairs at Johnson & Johnson, and Sara Garbin, Senior Clinical Development Scientist at Philips, were joined by Dr. Bassil Akra, founder and CEO of AKRA Team GmbH, to...
Dual Screening in Your Systematic Review Process: Is it Worth the Time?
Dual independent screening in your systematic review process is undoubtedly considered a best practice. But for some research teams, a lack of resources precludes this from being a standard operating procedure. New evidence reinforces the value in dual screening, and...